• レポートコード:TMR2008055 • 出版社/出版日:Transparency Market Research / 2020年5月 • レポート形態:英文、PDF、242ページ • 納品方法:Eメール • 産業分類:医薬品 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは水銀中毒治療の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、薬物別(キレート剤、キレート剤併用療法、血漿交換血液透析血漿交換)分析、種類別(急性水銀中毒、慢性水銀中毒)分析、治療別(支持療法、解毒剤治療)分析、フォーム別(無機水銀、エレメンタル水銀、有機水銀)分析、投与経路別(注射剤、経口)分析、流通チャンネル別(病院薬局、オンライン薬局、小売薬局)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場見通し ・水銀中毒治療の世界市場:薬物別(キレート剤、キレート剤併用療法、血漿交換血液透析血漿交換) ・水銀中毒治療の世界市場:種類別(急性水銀中毒、慢性水銀中毒) ・水銀中毒治療の世界市場:治療別(支持療法、解毒剤治療) ・水銀中毒治療の世界市場:フォーム別(無機水銀、エレメンタル水銀、有機水銀) ・水銀中毒治療の世界市場:投与経路別(注射剤、経口) ・水銀中毒治療の世界市場:流通チャンネル別(病院薬局、オンライン薬局、小売薬局) ・水銀中毒治療の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ) ・競争状況 |
Mercury Poisoning Treatment Market – Scope of the Report
TMR’s report on the global mercury poisoning treatment market studies past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global mercury poisoning treatment market for period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global mercury poisoning treatment market for the same period.
The report has been prepared after extensive research. Primary research involved a bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global mercury poisoning treatment market.
Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global mercury poisoning treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global mercury poisoning treatment market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global mercury poisoning treatment market. The next section of the report highlights the USPs, which includes, mercury poisoning overview, research & development strategies & pipeline analysis, treatment cost globally by key regions, drug prices globally by key regions, and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).
The report delves into the competition landscape of the global mercury poisoning treatment market. Key players operating in the global mercury poisoning treatment market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global mercury poisoning treatment market profiled in this report.
Key Questions Answered in Report on Mercury Poisoning Treatment Market
What are the major drivers, restraints, and opportunities in the global mercury poisoning treatment market?
What would be the revenue share projection of key segments of the global mercury poisoning treatment market during the forecast period?
Which segment is likely to lead the global mercury poisoning treatment market, in terms of revenue, between 2020 and 2030?
How mergers & acquisitions among players are widening the scope for the global mercury poisoning treatment market?
What is the market position of different companies operating in the global mercury poisoning treatment market?
Mercury Poisoning Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global mercury poisoning treatment market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global mercury poisoning treatment market. It is followed by market introduction, market dynamics, and an overview of the global mercury poisoning treatment market, which includes TMR’s analysis of market drivers, restraints, and trends pertaining to the global mercury poisoning treatment market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global mercury poisoning treatment market. The next section of the global mercury poisoning treatment report highlights the USPs, which include mercury poisoning overview, research & development strategies & pipeline analysis, treatment cost globally by key regions, drug prices globally by key regions, and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report segments the global mercury poisoning treatment market in terms of drug, type, treatment type, form, route of administration, distribution channel, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global mercury poisoning treatment market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mercury Poisoning Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Mercury Poisoning Treatment Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. Mercury Poisoning Overview
5.2. Research and Development Strategies & Pipeline Analysis
5.3. Treatment Cost – Global – By Key Regions
5.4. Drug Prices – Global – By Key Regions
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis
6. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug
6.1. Introduction & Definition
6.2. Global Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
6.2.1. Chelating Agents
6.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
6.2.1.2. Dimercaptosuccinic Acid (DMSA)
6.2.1.3. DMPS
6.2.1.4. Penicillamine
6.2.1.5. Others
6.2.2. Combination Therapy with Chelating Agents
6.2.3. Plasma Exchange Hemodialysis Plasmapheresis
6.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug
7. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type
7.1. Introduction & Definition
7.2. Global Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
7.2.1. Acute Mercury Poisoning
7.2.2. Chronic Mercury Poisoning
7.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Type
8. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type
8.1. Introduction
8.2. Global Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
8.2.1. Supportive Treatment
8.2.2. Antidotal Treatment
8.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type
9. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form
9.1. Introduction
9.2. Global Mercury Poisoning Treatment Market Value Forecast, by Form, 2018–2030
9.2.1. Inorganic Mercury
9.2.2. Elemental Mercury
9.2.3. Organic Mercury
9.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Form
10. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration
10.1. Introduction
10.2. Global Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
10.2.1. Injectable
10.2.2. Oral
10.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration
11. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel
11.1. Introduction
11.2. Global Mercury Poisoning Treatment Market Value Forecast, by End-user, 2018–2030
11.2.1. Hospital Pharmacies
11.2.2. Online Pharmacies
11.2.3. Retail Pharmacies
11.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by End-user
12. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region
12.1. Introduction
12.2. Global Mercury Poisoning Treatment Market Value Forecast, by Region, 2018–2030
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Region
13. North America Mercury Poisoning Treatment Market Analysis and Forecast
13.1. Introduction
13.2. North America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
13.2.1. Chelating Agents
13.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
13.2.1.2. Dimercaptosuccinic Acid (DMSA)
13.2.1.3. DMPS
13.2.1.4. Penicillamine
13.2.1.5. Others
13.2.2. Combination Therapy with Chelating Agents
13.2.3. Plasma Exchange Hemodialysis Plasmapheresis
13.3. North America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
13.3.1. Acute Mercury Poisoning
13.3.2. Chronic Mercury Poisoning
13.4. North America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
13.4.1. Supportive Treatment
13.4.2. Antidotal Treatment
13.5. North America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
13.5.1. Inorganic Mercury
13.5.2. Elemental Mercury
13.5.3. Organic Mercury
13.6. North America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
13.6.1. Injectable
13.6.2. Oral
13.7. North America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
13.7.1. Hospital Pharmacies
13.7.2. Online Pharmacies
13.7.3. Retail Pharmacies
13.8. North America Mercury Poisoning Treatment Market Value Forecast, by Country, 2018–2030
13.8.1. U.S.
13.8.2. Canada
13.9. North America Mercury Poisoning Treatment Market Attractiveness Analysis
13.9.1. By Drug
13.9.2. By Type
13.9.3. By Treatment Type
13.9.4. By Form
13.9.5. By Route of Administration
13.9.6. By Distribution Channel
13.9.7. By Country
14. Europe Mercury Poisoning Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Europe Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
14.2.1. Chelating Agents
14.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
14.2.1.2. Dimercaptosuccinic Acid (DMSA)
14.2.1.3. DMPS
14.2.1.4. Penicillamine
14.2.1.5. Others
14.2.2. Combination Therapy with Chelating Agents
14.2.3. Plasma Exchange Hemodialysis Plasmapheresis
14.3. Europe Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
14.3.1. Acute Mercury Poisoning
14.3.2. Chronic Mercury Poisoning
14.4. Europe Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
14.4.1. Supportive Treatment
14.4.2. Antidotal Treatment
14.5. Europe Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
14.5.1. Inorganic Mercury
14.5.2. Elemental Mercury
14.5.3. Organic Mercury
14.6. Europe Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
14.6.1. Injectable
14.6.2. Oral
14.7. Europe Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
14.7.1. Hospital Pharmacies
14.7.2. Online Pharmacies
14.7.3. Retail Pharmacies
14.8. Europe Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
14.8.1. Germany
14.8.2. U.K.
14.8.3. France
14.8.4. Spain
14.8.5. Italy
14.8.6. Rest of Europe
14.9. Europe Mercury Poisoning Treatment Market Attractiveness Analysis
14.9.1. By Drug
14.9.2. By Type
14.9.3. By Treatment Type
14.9.4. By Form
14.9.5. By Route of Administration
14.9.6. By Distribution Channel
14.9.7. By Country/Sub-region
15. Asia Pacific Mercury Poisoning Treatment Market Analysis and Forecast
15.1. Introduction
15.2. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
15.2.1. Chelating Agents
15.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
15.2.1.2. Dimercaptosuccinic Acid (DMSA)
15.2.1.3. DMPS
15.2.1.4. Penicillamine
15.2.1.5. Others
15.2.2. Combination Therapy with Chelating Agents
15.2.3. Plasma Exchange Hemodialysis Plasmapheresis
15.3. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
15.3.1. Acute Mercury Poisoning
15.3.2. Chronic Mercury Poisoning
15.4. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
15.4.1. Supportive Treatment
15.4.2. Antidotal Treatment
15.5. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
15.5.1. Inorganic Mercury
15.5.2. Elemental Mercury
15.5.3. Organic Mercury
15.6. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
15.6.1. Injectable
15.6.2. Oral
15.7. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
15.7.1. Hospital Pharmacies
15.7.2. Online Pharmacies
15.7.3. Retail Pharmacies
15.8. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
15.8.1. Japan
15.8.2. China
15.8.3. India
15.8.4. Australia & New Zealand
15.8.5. Rest of Asia Pacific
15.9. Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis
15.9.1. By Drug
15.9.2. By Type
15.9.3. By Treatment Type
15.9.4. By Form
15.9.5. By Route of Administration
15.9.6. By Distribution Channel
15.9.7. By Country/Sub-region
16. Latin America Mercury Poisoning Treatment Market Analysis and Forecast
16.1. Introduction
16.2. Latin America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
16.2.1. Chelating Agents
16.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
16.2.1.2. Dimercaptosuccinic Acid (DMSA)
16.2.1.3. DMPS
16.2.1.4. Penicillamine
16.2.1.5. Others
16.2.2. Combination Therapy with Chelating Agents
16.2.3. Plasma Exchange Hemodialysis Plasmapheresis
16.3. Latin America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
16.3.1. Acute Mercury Poisoning
16.3.2. Chronic Mercury Poisoning
16.4. Latin America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
16.4.1. Supportive Treatment
16.4.2. Antidotal Treatment
16.5. Latin America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
16.5.1. Inorganic Mercury
16.5.2. Elemental Mercury
16.5.3. Organic Mercury
16.6. Latin America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
16.6.1. Injectable
16.6.2. Oral
16.7. Latin America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
16.7.1. Hospital Pharmacies
16.7.2. Online Pharmacies
16.7.3. Retail Pharmacies
16.8. Latin America Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Latin America Mercury Poisoning Treatment Market Attractiveness Analysis
16.9.1. By Drug
16.9.2. By Type
16.9.3. By Treatment Type
16.9.4. By Form
16.9.5. By Route of Administration
16.9.6. By Distribution Channel
16.9.7. By Country/Sub-region
17. Middle East & Africa Mercury Poisoning Treatment Market Analysis and Forecast
17.1. Introduction
17.2. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
17.2.1. Chelating Agents
17.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
17.2.1.2. Dimercaptosuccinic Acid (DMSA)
17.2.1.3. DMPS
17.2.1.4. Penicillamine
17.2.1.5. Others
17.2.2. Combination Therapy with Chelating Agents
17.2.3. Plasma Exchange Hemodialysis Plasmapheresis
17.3. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
17.3.1. Acute Mercury Poisoning
17.3.2. Chronic Mercury Poisoning
17.4. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
17.4.1. Supportive Treatment
17.4.2. Antidotal Treatment
17.5. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
17.5.1. Inorganic Mercury
17.5.2. Elemental Mercury
17.5.3. Organic Mercury
17.6. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
17.6.1. Injectable
17.6.2. Oral
17.7. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
17.7.1. Hospital Pharmacies
17.7.2. Online Pharmacies
17.7.3. Retail Pharmacies
17.8. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of Middle East & Africa
17.9. Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis
17.9.1. By Drug
17.9.2. By Type
17.9.3. By Treatment Type
17.9.4. By Form
17.9.5. By Route of Administration
17.9.6. By Distribution Channel
17.9.7. By Country/Sub-region
18. Competition Landscape
18.1. Market Player – Competition Matrix (By Tier and Size of companies)
18.2. Global Mercury Poisoning Treatment Market Position Analysis, by Company, 2019
18.3. Company Profiles
18.3.1. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
18.3.1.1. Company Description
18.3.1.2. Business Overview
18.3.1.3. Strategic Overview
18.3.1.4. SWOT Analysis
18.3.2. Genex Pharma
18.3.2.1. Company Description
18.3.2.2. Business Overview
18.3.2.3. Strategic Overview
18.3.2.4. SWOT Analysis
18.3.3. RECORDATI S.p.A. (Recordati Rare Diseases)
18.3.3.1. Company Description
18.3.3.2. Business Overview
18.3.3.3. Financial Overview
18.3.3.4. Strategic Overview
18.3.3.5. SWOT Analysis
18.3.4. Mylan N.V.
18.3.4.1. Company Description
18.3.4.2. Business Overview
18.3.4.3. Strategic Overview
18.3.4.4. Financial Overview
18.3.4.5. SWOT Analysis
18.3.5. Akorn, Incorporated
18.3.5.1. Company Description
18.3.5.2. Business Overview
18.3.5.3. Strategic Overview
18.3.5.4. Financial Overview
18.3.5.5. SWOT Analysis
18.3.6. EmeraMed Limited
18.3.6.1. Company Description
18.3.6.2. Business Overview
18.3.6.3. SWOT Analysis
18.3.7. Sanofi
18.3.7.1. Company Description
18.3.7.2. Business Overview
18.3.7.3. Strategic Overview
18.3.7.4. SWOT Analysis
List of TablesTable 01 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 02 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 03 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 04 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type 2018–2030
Table 05 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 06 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 07 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 08 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 10 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 11 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 12 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 13 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 14 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 15 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 16 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 17 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 19 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 20 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 21 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 22 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 23 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 24 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 25 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 27 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 28 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 29 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 30 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 31 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 32 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 33 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 34 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 35 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 36 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 37 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 38 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 39 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 40 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 41 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 42 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 43 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 44 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 45 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 46 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 47 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 48 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030